Home >> Marketplace Directory >> MPLN acquires MiSeqDx, 1/14

MPLN acquires MiSeqDx, 1/14

image_pdfCreate PDF

January 2014—Molecular Pathology Laboratory Network has acquired the Illumina MiSeqDx and will use the system to expand testing across all of its clinical laboratories, including its clinical trials group Geneuity Clinical Research Services. MPLN is a molecular reference laboratory specializing in oncology, women’s health, and clinical research services.

MPLN, 865-380-9746

CAP TODAY
X